Skip to Main content Skip to Navigation
Journal articles

Genomics applied to the treatment of breast cancer

Abstract : Breast cancer remains a major health issue in the world with 1.7 million new cases in 2012 worldwide. It is the second cause of death from cancer in western countries. Genomics have started to modify the treatment of breast cancer, and the developments should become more and more significant, especially in the present era of treatment personalization and with the implementation of new technologies. With molecular signatures, genomics enabled a de-escalation of chemotherapy and personalized treatments of localized forms of estrogen-dependent breast cancers. Genomics can also make a real contribution to constitutional genetics, so as to identify mutations in a panel of candidate genes. In this review, we will discuss the contributions of genomics applied to the treatment of breast cancer, whether already validated contributions or possible future applications linked to research data.
Complete list of metadatas

Cited literature [112 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02545178
Contributor : Philippe Ratajczak <>
Submitted on : Thursday, April 16, 2020 - 6:51:01 PM
Last modification on : Friday, October 23, 2020 - 4:51:40 PM

Identifiers

Collections

Citation

Diaddin Hamdan, Thi Thuy Nga Nguyen, Christophe Leboeuf, Solveig Meles, Anne Janin, et al.. Genomics applied to the treatment of breast cancer. Oncotarget, Impact journals, 2019, 10 (46), pp.4786-4801. ⟨10.18632/oncotarget.27102⟩. ⟨inserm-02545178⟩

Share

Metrics

Record views

198

Files downloads

101